- 询价
- Signalway Antibody
- USA
- C45604
- 2026年03月15日
- Rabbit
- Hu
企业认证
相关产品推荐更多 >
![PFDN2 Antibody[47343]](https://img1.dxycdn.com/p/s14/2025/0923/496/0462304380155040791.jpg!wh200)
![Cathepsin LVKH Conjugated Antibody[C49457]](https://img1.dxycdn.com/p/s14/2025/0923/305/2150219664296040791.jpg!wh200)
![HNRNPD Rabbit Polyclonal Antibody[54072]](https://img1.dxycdn.com/p/s14/2025/0922/498/0460884283108299691.jpg!wh200)
![AKT1/3 (Phospho-Tyr437/434) Antibody[12116]](https://img1.dxycdn.com/p/s14/2025/0922/359/6146153295428599691.jpg!wh200)
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
A synthesized peptide derived from human DRD1IP
- 形态：
liquid
- 保存条件：
Store at 4˚C
- 克隆性：
多克隆
- 标记物：
AF350: 346nm/442nm <br/>AF405: 401nm/421nm <br/>AF488: 493nm/519nm <br/>AF555: 555nm/565nm <br/>AF594: 591nm/614nm <br/>AF647: 651nm/667nm <br/>AF680: 679nm/702nm <br/>AF750: 749nm/775nm <br/>Biotin
- 适应物种：
Hu
- 保质期：
6 months
- 库存：
详询
- 宿主：
Rabbit
- 抗体英文名：
DRD1IP Conjugated Antibody
- 规格：
100ul
Suggested Dilution:
AF350 conjugated: most applications: 1: 50 - 1: 250
AF405 conjugated: most applications: 1: 50 - 1: 250
AF488 conjugated: most applications: 1: 50 - 1: 250
AF555 conjugated: most applications: 1: 50 - 1: 250
AF594 conjugated: most applications: 1: 50 - 1: 250
AF647 conjugated: most applications: 1: 50 - 1: 250
AF680 conjugated: most applications: 1: 50 - 1: 250
AF750 conjugated: most applications: 1: 50 - 1: 250
Biotin conjugated: working with enzyme-conjugated streptavidin，most applications: 1: 50 - 1: 1,000
specificity:
DRD1IP Antibody detects endogenous levels of total DRD1IP
accession_no:
Swiss-Prot#:Q9NYX4
NCBI Gene ID:50632
NCBI mRNA#:
NCBI Protein#:formulation:
0.01M Sodium Phosphate, 0.25M NaCl, pH 7.6, 10mg/ml Bovine Serum Albumin, 0.05% Sodium Azide
产品详细信息请点击：DRD1IP Conjugated Antibody
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验） 2、Input 条带清晰，co-IP 条带很弱？ 设X为诱饵蛋白，Y 为靶蛋白，有可能为 X 和 Y 的相互作用本身比较弱 X 蛋白并不是 Y 的唯一，只部分 Y 与 X 互作 可以尝试反向拉，比如用 Y 去拉 X，可能效果比较好 3、我的 p 53 蛋白正好和抗体重链分子量接近，要如何减少抗体干扰？ 建议方案： IP/WB 一抗使用不同种属来源，选择与IP抗体种属无交叉反应的二抗（Cross Adsorbed secondary antibody） 特殊二抗：比如仅识别重链或者轻链的二抗，或者仅
Fluoroimmunoassays Using Antibody-Conjugated Quantum Dots
between negatively charged dihydrolipoic acid (DHLA)-capped CdSe-ZnS core-shell quantum dots and positively charged proteins (natural or engineered) that serve to bridge the quantum dot and antibody. This chapter details the materials and methods for synthesis
IP Issues in the Therapeutic Antibody Industry
The following section is related to IP issues in the therapeutic Antibody industry. A rough overview over protected enabling techniques and compounds is provided, in order to facilitate the entry into freedom to operate studies. Furthermore
技术资料暂无技术资料 索取技术资料
